
Hims & Hers Boost Global Reach with Zava Acquisition and European Expansion
Hims & Hers Health's stock rose over 6% following the announcement of its pending acquisition of ZAVA, a European digital health platform, which will expand its presence into the UK, Germany, France, and Ireland, aiming to deliver personalized healthcare globally. The deal, expected to close in late 2025 and funded by cash, will add ZAVA's 1.3 million active customers and nearly 2.3 million consultations last year.





